Professor Keertan Dheda has received of several prestigious awards including the 2014 Oppenheimer Award, and has published over 160 peer-reviewed papers and holds 3 patents related to new TB diagnostic or infection control technologies. He serves on the editorial board of the journals PLoS One, the International Journal of Tuberculosis and Lung Disease, American Journal of Respiratory and Critical Medicine, Lancet Respiratory Diseases and Nature Scientific Reports, amongst his full biography at the University of Cape Town Lung Institute
Talk to your doctor and if necessary, see an allergy specialist to help identify your trigger/s so you can avoid them. Your doctor should help you develop an anaphylaxis action plan, explaining how to recognise an anaphylactic reaction, what to do, medications to use (such as an adrenaline injector) and when to call an ambulance. The doctor will also explain when to return for regular follow up visits. It is also important that people around you (. at work, school etc) know about anaphylaxis and how to help if you have a reaction.
This drug seems to have a beneficial effect similar to that of omalizumab (Xolair), said Neil Schachter, MD, professor of medicine at Mount Sinai School of Medicine, in New York City, who was not involved with the study. Benralizumab, mepolizumab, and reslizumab "have an advantage over Xolair in that they seem to be effective with fewer dosings" -- with Xolair being given every 2-4 weeks versus up to 8 weeks for the other medications. In addition, "these drugs seem to be well-tolerated and have few side effects of their own over the long run."